You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 23, 2024

THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Theophylline 0.4% And Dextrose 5% In Plastic Container patents expire, and when can generic versions of Theophylline 0.4% And Dextrose 5% In Plastic Container launch?

Theophylline 0.4% And Dextrose 5% In Plastic Container is a drug marketed by B Braun and is included in two NDAs.

The generic ingredient in THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Theophylline 0.4% And Dextrose 5% In Plastic Container

A generic version of THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Sign Up

AI Research Assistant
Sample questions
  • What is the 5 year forecast for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical College of WisconsinPhase 1/Phase 2
University of OklahomaPhase 1/Phase 2
University of California, Los AngelesEarly Phase 1

See all THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019212-003 Nov 7, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
B Braun THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019212-002 Nov 7, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
B Braun THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019826-005 Aug 14, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.